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Abstract
PLCE1 encodes phospholipase C epsilon, and its mutations cause recessive nephrotic syndrome. However, the
mechanisms by which PLCE1 mutations result in defects associated with glomerular function are not clear. To address
this, we investigated the function of PLCE1 in podocytes called glomerular epithelial cells, where the pathogenesis of
nephrotic syndrome converges. PLCE1 colocalized with Rho GTPases in glomeruli. Further, it interacted with Rho
GTPases through the pleckstrin homology domain and Ras GTP-binding domains 1/2. Knockdown or knockout of
PLCE1 in podocytes resulted in decreased levels of GTP-bound Rac1 and Cdc42, but not those of RhoA, and caused a
reduction in cell migration. PLCE1 interacted with NCK2 but not with NCK1. Similar to the PLCE1 knockout, NCK2
knockout resulted in decreased podocyte migration. Knockout of PLCE1 reduced the EGF-induced activation of ERK
and cell proliferation in podocytes, whereas knockout of NCK2 did not affect proliferation. Further, the knockout of
PLCE1 also resulted in decreased expression of podocyte markers, including NEPH1, NPHS1, WT1, and SYNPO, upon
differentiation, but the knockout of NCK2 did not affect the expression of these markers. Therefore, our findings
demonstrate that PLCE1 regulates Rho GTPase activity and cell migration through interacting with NCK2 and that
PLCE1 also plays a role in the proliferation and differentiation of podocytes, regardless of the presence of NCK2.
Introduction
Filtration is an important function of the kidneys, and
the human kidney contains one million glomeruli (filtering
units). Glomeruli consist of three cell types: podocytes,
endothelial cells, and mesangial cells1. Podocytes are
neuron-like terminally differentiated epithelial cells that
contain three segments: the cell body, major processes,
and foot processes. The foot processes are in direct contact
with the urinary side of the glomerular basement mem-
brane and interdigitate with the foot processes from
neighboring cells through specialized intercellular junc-
tions (the ‘slit diaphragm’), thereby forming sieve-like
structures that prevent the loss of plasma proteins into the
urine1. This structure serves to create a maximal filtration
space between cells while simultaneously supporting and
maintaining the glomerular basement membrane2.
Defects in the glomerular filter result in nephrotic
syndrome, a kidney disease characterized by albumin loss
(proteinuria). Nephrotic syndrome is classified as either
steroid-sensitive or steroid-resistant, depending on the
response to steroids, which are commonly used as first-
line therapy3. A significant proportion of steroid-resistant
nephrotic syndromes (SRNSs) have a genetic background
and result from a single-gene defect. The genetic het-
erogeneity of SRNS can be demonstrated by the fact that
mutations in approximately 50 genes have been identified
to be capable of causing SRNS4,5. Research on the func-
tion of genes linked to SRNS has revealed that podocytes
are critical sites for the pathogenesis of SRNS6,7. SRNS is
accompanied by the rearrangement of the actin cytoske-
leton and simplification of interdigitating cellular pro-
cesses of podocytes, called foot process effacement, which
is a classic feature of proteinuric kidney diseases, includ-
ing SRNS7.
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Mutations in PLCE1, the gene encoding phospholipase
C epsilon 1, have been described in patients with early-
onset nephrotic syndrome8. In individuals exhibiting
PLCE1 mutations, kidney histology shows diffuse
mesangial sclerosis (DMS) in most cases and focal seg-
mental glomerulosclerosis (FSGS) in others9. Members of
the phosphoinositide-specific phospholipase C family
catalyze the hydrolysis of membrane phospholipids to
generate the second messenger molecules inositol 1,4,5-
trisphosphate (IP3) and diacylglycerol (DAG), which
initiate intracellular cell growth and differentiation path-
ways10. PLCE1 is activated by G proteins, such as Gα12/13,
and small GTPases, such as Ras and RhoA11,12. DAG is an
agonist of TRPC6, whose gain-of-function mutations
cause late-onset nephrotic syndrome13,14. Therefore, it
was shown that loss of PLCE1 can lead to disturbed DAG-
mediated TRPC6 activation. However, podocytes isolated
from Plce1−/− mice were indistinguishable from control
podocytes with respect to TRPC6 activation, indicating a
redundancy in the PLC function in podocytes in this
particular context15.
The role of PLCE1 in podocytes and the pathogenesis of
nephrotic syndrome due to the loss of PLCE1 are not well
understood. To address this, PLCE1-deficient podocytes
were examined, and it was found that the migration,
proliferation, and maturation of podocytes were nega-
tively affected by the loss of PLCE1, thereby revealing a
link between PLCE1 mutations and podocytopathy.
Materials and methods
Plasmids, cell culture, and transfection
The human PLCE1 clone has been described previously8.
The fragments of PLCE1 were subcloned into pEGFP-C1
(Clontech, Mountain View, CA, USA). NCK1 and NCK2
clones were purchased from the Harvard PlasmID Data-
base. Immortalized human podocytes were provided by
Moin Saleem (University of Bristol, Bristol, UK) and
maintained in RPMI plus GlutaMAX-I (Gibco) supple-
mented with 10% FBS, penicillin–streptomycin (50 IU/ml
and 50 μg/ml, respectively), and insulin-transferrin-
selenium-X. Plasmids and siRNA were transfected into
podocytes cultured at a permissive temperature of 33 °C
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA).
Podocytes were cultured for differentiation at 37 °C for
14 days. The PLCE1-specific and control scrambled siRNAs
were purchased from Qiagen. HEK293 or Lenti-X
293 T cells were propagated in DMEM supplemented
with 10% FBS and penicillin–streptomycin (50 IU/ml and
50 μg/ml, respectively). sgRNAs targeting human NCK2
(sgRNA1, 5’-GCTATGTACCGTCCAACTACG-3’; sgRNA
2, 5’-GTGGACATCAAGAAGAACGAG-3’; and sgRNA3,
5’-GTACCGTCCAACTACGTGGAG-3’) and human PLC
E1 (sgRNA1, 5’-GCCAGCCTCCGAGACAGCCCA-3’; sgR
NA2, 5’-GCCCATGGAAGGATAAGCGT-3’; and sgRNA
3, 5’-GACTTCTTGCTCCCAAAGACG-3’) were cloned
into BsmBI-digested lentiCRISPR v2 (Addgene #52961,
Watertown, MA, USA). To establish PLCE1 or NCK2
knockout cell lines, lentiCRISPR v2, pMD2.G, and psPAX2
were transfected into Lenti-X 293T cells (Clontech). The
supernatant containing lentivirus was collected 48 h after
transfection and passed through a 0.2 µm filter. Cultured
podocytes were transduced with lentivirus containing len-
tiCRISPR clones, selected, and maintained in the presence
of 4 μg/ml puromycin.
Immunoblotting, GST pulldown, and immunoprecipitation
These experiments were performed as described pre-
viously16. GST-Rac1 (Addgene, #12200) and GST-RhoA
(Addgene, #12202) were purified from the BL21 (DE3) E.
coli strain, and GST-PAK1 CRIB and GST-rhotekin RBD
domains were purchased from Cytoskeleton, Inc. Anti-
FLAG, anti-Myc, anti-p-ERK, anti-p-JNK, anti-ERK (Cell
Signaling Technology, Danvers, MA, USA), anti-Rac1,
anti-Cdc42 (BD Transduction Laboratories), anti-RhoA
(Santa Cruz Biotechnology, Dallas, TX, USA), and anti-
GFP (Invitrogen) were purchased from the indicated
commercial sources. The anti-PLCE1 antibody has been
previously described by Hinkes et al.8. Coimmunopreci-
pitation was performed using EZview Red anti-FLAG M2
or Anti-c-Myc Affinity Gels (Sigma-Aldrich, St.Louis,
MO, USA). The intensities of immunoblots were analyzed
using ImageJ.
Immunofluorescence
The rat kidney tissue was fixed in 4% paraformaldehyde
overnight at 4 °C, embedded in paraffin blocks, and cut
into 5 μm-thick sections. The sections were then mounted
on slides, deparaffinized, and rehydrated through a graded
series of ethanol concentrations. After rehydration, anti-
gen retrieval was performed by boiling the sections for
30min using a Retrieve-All Antigen unmasking system 1
(pH 8; BioLegend, San Diego, CA, USA). Sections were
permeabilized with 1% sodium dodecyl sulfate for 10 min
at room temperature, blocked with normal donkey serum
(1% BSA, 10% donkey serum in PBS) for 1 h, and incu-
bated overnight with primary antibodies. The next day,
sections were washed with PBS and incubated with sec-
ondary antibodies, Alexa 488 and Alexa 594 (Invitrogen);
the sections were then washed with PBS, stained with
DAPI and mounted on coverslips. Fluorescence images
were obtained using an LSM 780 confocal microscope
(Carl Zeiss).
Wound-healing assay
Cells were seeded in 96-well image lock plates (Essen
Bioscience, Ann Arbor, MI, USA). Podocytes were
examined for confluency as a monolayer via light
microscopy before the initiation of the wound-healing
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assay. Scratches were made using a 96-pin tool
(Woundmaker), according to the protocol provided by
the manufacturer.
Podocyte migration and proliferation assays
Real-time migration or proliferation assays were per-
formed using the xCELLigence system (ACEA Bios-
ciences, Inc, San Diego, CA, USA), according to the
manufacturer’s instructions. Briefly, 2 × 104 cells were
seeded in an E-Plate for the proliferation assay and were
treated with 100 ng/ml epidermal growth factor. For the
migration assay, 4 × 104 cells were seeded in serum-free
media in the upper chamber of a CIM-Plate 16, while the
lower chambers were filled with 10% FBS for chemoat-
traction or with serum-free media. The data were ana-
lyzed using RTCA software. The results are presented as
the time-versus-cell index.
Quantitative RT-PCR
Total RNA was extracted from podocytes and reverse-
transcribed using the iScriptTM Select cDNA Synthesis Kit
(Bio-Rad, Hercules, CA), according to the manufacturer’s
instructions. Target amplification was performed in 96-well
plates using the StepOnePlusTM Real-Time PCR System
and SYBR Green PCR Master Mix (Thermo Fisher Scien-
tific, San Jose, CA, USA), according to the manufacturer’s








5’-TGCCCTTCTGTCCATTTC-3’). All samples were run
in triplicate. The relative RNA expression levels were cal-
culated via a comparative threshold cycle (Ct) method using
GAPDH as the control: ΔCt=Ct(GAPDH)-Ct(target gene).
The fold change in the gene expression, which was nor-
malized to GAPDH and relative to the control sample, was
calculated as 2−ΔΔCt.
Statistical analysis
The results are presented as the means ± SEM or SD for
the indicated number of experiments. Statistical analysis
of continuous data was performed with a 2-tailed Stu-
dent’s t-test or a Mann–Whitney U test, as appropriate.
P < 0.05 was considered statistically significant.
Results
PLCE1 interacts with RhoA and Rac1 in podocytes
PLCE1 is activated by the direct binding of small
GTPases, including Ras and RhoA11,12. As Rac1, Cdc42,
and RhoA are implicated in the pathogenesis of nephrotic
syndrome in mice and humans16–20, we examined whe-
ther these Rho GTPases interact with PLCE1 in cultured
podocytes. Coimmunoprecipitation in the background of
PLCE1 overexpression revealed that PLCE1 interacts with
Rac1 (Fig. 1a) and RhoA (Fig. 1b) but not with Cdc42 (Fig.
1c). The interaction of PLCE1 with Rac1 and RhoA was
further confirmed by the pulldown assay (Fig. 1d, e).
The expression of PLCE1 in the glomeruli was exam-
ined. PLCE1 has been reported to be expressed in devel-
oping and mature podocytes8, and we also confirmed that
PLCE1 is enriched in podocyte cell bodies and processes
by staining for the podocytic markers WT1 and
SYNAPTOPODIN using immunofluorescence (Fig. 1f, g).
Immunostaining of PLCE1 with Rac1 showed the colo-
calization of both proteins in cell bodies and the processes
of podocytes (Fig. 1h), whereas PLCE1 colocalized with
RhoA mostly in the cell bodies (Fig. 1i).
To identify the domain of PLCE1 that interacts with
Rac1 and RhoA, coimmunoprecipitation was performed
in cultured podocytes (Fig. 2). PLCE1 contains a RasGEF
(a.k.a., CDC25, guanine nucleotide exchange factor for
Ras-like small GTPases) domain, a pleckstrin homology
(PH) domain, two regions with high sequence conserva-
tion among all PLCs (X and Y), a C2 domain, and two
Ras-binding (RA) domains (Fig. 2a)12. Among these, both
Rac1 and RhoA bind to PLCE1 through the PH and RA1/
2 domains (Fig. 2b, c).
Loss of PLCE1 resulted in decreased active Rac1 and Cdc42
and decreased podocyte migration
As PLCE1 interacts with Rac1 and RhoA in podo-
cytes, the effect of PLCE1 on the active states of Rho
GTPases was examined. PLCE1 was knocked down
using siRNAs, and pulldown assays were performed
using purified PAK1 and Rhotekin. Knockdown of
PLCE1 in cultured podocytes led to a decrease in active
GTP-bound Rac1 (43%) and Cdc42 (40%) (Fig. 3a–c)
but had no effect on the levels of active RhoA in the
cultured podocytes (Fig. 3d, e).
As Rho GTPases regulate cell migration21 and PLCE1
knockdown alters the active status of Rac1 and Cdc42,
podocyte migration was examined using two different
approaches. In the wound-healing assay, podocytes with
siRNA-mediated PLCE1 knockdown exhibited delayed
wound closure compared to the control podocytes (Fig.
4a, b). This result is consistent with the findings of Rao
et al.5. In addition, the Boyden chamber assay using the
xCELLigence system showed that the knockdown of
PLCE1 resulted in a decreased migratory phenotype in
cultured podocytes (Fig. 4c).
As Rho GTPases play an important role in organizing
the actin cytoskeleton, thereby affecting the cell mor-
phology21, we examined podocyte morphology in the
background of the PLCE1 knockout (KO) (Supplementary
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Fig. 1). PLCE1 KO resulted in the loss of terminal
arborizations in undifferentiated podocytes (Fig. 4d).
Furthermore, differentiated PLCE1 KO podocytes dis-
played increased stress fibers, reflecting damage to the
podocyte architecture (Fig. 4e)22.
Taken together, the loss of PLCE1 resulted in decreased
active Rac1 and Cdc42, thereby leading to a reduced
migratory phenotype in cultured podocytes.
PLCE1 interacts with NCK2 in podocytes
NCK proteins, NCK1 and NCK2, are ubiquitously
expressed adaptors that contain three Src homology 3 (SH3)
domains and an SH2 domain; a podocyte-specific deletion of
both genes leads to FSGS23. Coimmunoprecipitation was
performed to investigate the interaction between PLCE1 and
NCKs; this was based on the prediction of a web-based
protein-protein interaction database, PrePPI (https://bhapp.
c2b2.columbia.edu/PrePPI/), which showed that PLCE1 can
interact with NCKs. The results showed that PLCE1 inter-
acted with NCK2 but not with NCK1 (Fig. 5a, b).
NCKs relay signals from receptors at the plasma
membrane to the actin cytoskeleton by simulating N-
WASP-Arp2/3-induced actin nucleation24 or by activat-
ing Pak125. As NCK2 interacts with PLCE1, the effect of
NCK2 on podocyte migration was examined. Therefore,
NCK2 was knocked out in cultured podocytes using the
CRISPR/Cas9 system (Supplementary Fig. 2). NCK2
knockout (KO) podocytes exhibited decreased migration
in a manner similar to podocytes with PLCE1 knockdown
(Fig. 5c). These results suggest that PLCE1 cooperates
with NCK2 to regulate the actin cytoskeleton in
podocytes.
PLCE1 regulates the activity of mitogen-activated protein
kinases in podocytes
PLCE1 transduces mitogenic signals through its activity
as a RasGEF to stimulate the Ras and mitogen-activated
protein kinase (MAPK) signaling pathway11,26. To investi-
gate whether PLCE1 plays a similar function in podocytes,
we investigated the Ras/MAPK signaling pathway. Upon
Fig. 1 PLCE1 interacts with Rac1 and RhoA. a–c Immunoprecipitation of PLCE1 with Rho GTPase, Rac1 (a), RhoA (b), and Cdc42 (c) in cultured
podocytes. Immunoblotting showed that PLCE1 interacts with Rac1 and RhoA but not with Cdc42. d–e FLAG-PLCE1 expressed in HEK293 cells was
precipitated by GST- Rac1 (d) and GST-RhoA (e). Ponceau red staining at the top shows the GST proteins used. f–i Costaining of PLCE1 with WT1 (f),
SYNAPTOPODIN (g), Rac1 (h) and RhoA (i) using immunofluorescence in adult rat glomeruli. PLCE1 colocalized with Rac1 and RhoA in podocyte cell
bodies. Immunoprecipitation (IP) and pulldown (PD) experiments are representative of more than three experiments.
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stimulation of the control podocytes with epidermal growth
factor (EGF), the levels of phosphorylated extracellular-
signal-regulated kinase (ERK) and c-Jun N-terminal kinase
(JNK) were increased after 45min, but they returned to
basal levels after 120min (Fig. 6a). However, the EGF-
induced phosphorylation of ERK and JNK was significantly
reduced in PLCE1 KO podocytes (Fig. 6a). In addition,
PLCE1 KO podocytes exhibited lower proliferation than the
control podocytes (Fig. 6b). However, NCK2 KO podocytes
showed proliferation similar to that of control podocytes
(Fig. 6c), indicating that NCK2 is not involved in the pro-
liferation of podocytes.
The effect of PLCE1 KO on podocyte differentiation was
examined as MAPKs regulate differentiation27. When
cultured at 37 °C for 14 days, the levels of podocyte
markers, such as NEPH1, NPHS1,WT1, and SYNPO, were
significantly reduced in the PLCE1 KO podocytes com-
pared to those in control podocytes, whereas no differ-
ence was observed between the NCK2 KO and control
podocytes with respect to differentiation (Fig. 6d).
Fig. 2 The PH and RA1/2 domains of PLCE1 are required for the interaction with Rac1 and RhoA. a Schematic representation of the PLCE1
domains. PLCE1 contains a RasGEF domain, a pleckstrin homology (PH) domain, two regions of sequence among PLCs (X and Y), a C2 domain, and
two Ras-binding (RA) domains. The numbers represent the amino acid positions. The fragments of PLCE1 were fused to GFP at their N-terminus. b, c
Interactions of PLCE1 domains with Rho GTPase Rac1 and RhoA. GFP-tagged PLCE1 fragments and Myc-tagged Rac1 (b) and RhoA (c) were
transfected into podocytes, and immunoprecipitation was performed using anti-Myc agarose beads. Notably, both RAC1 and RhoA bind to PLCE1
through the PH and RA1/2 domains.
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Taken together, PLCE1 is involved in mediating the
proliferation and differentiation of podocytes by regulat-
ing MAPKs independently of NCK2.
Discussion
In this study, it was found that PLCE1 is involved in the
regulation of Rho GTPases and MAPKs in podocytes (Fig.
7). It was also found that PLCE1 interacts with NCK2 but
not with NCK1. PLCE1 KO podocytes exhibit a decrease
in active GTP-bound Rac1 and Cdc42 and decreased
migration. In addition, PLCE1 KO podocytes show a
decrease in ERK phosphorylation and proliferation upon
EGF stimulation and a decrease in the expression of
podocyte markers upon differentiation.
PLCE1 is a multifunctional enzyme exhibiting phos-
pholipase as well as RasGEF activities26. In podocytes,
PLCE1 can be activated by the Gα protein upon the sti-
mulation of the angiotensin II receptor by angiotensin II.
Then, through its phospholipase activity, PLCE1 hydro-
lyzes phosphatidylinositol 4,5-bisphosphate, thereby gen-
erating DAG and IP3. DAG activates TRPC6, and IP3
activates a calcium channel located in the endoplasmic
reticulum, thereby contributing to the increase in the
intracellular Ca2+ concentration. In podocytes, PLCβ and
PLCE1 play a redundant role in angiotensin II-induced
DAG production, and angiotensin II-induced TRPC6
currents are normally generated in Plce1−/− podocytes15.
Fig. 3 The effects of the PLCE1 knockdown on Rho GTPase activity. a Active GTP-bound Rac1 and Cdc42 precipitated from podocytes
transfected with PLCE1 siRNA using a GST-PAK1 (CRIB domain) pulldown assay. Ponceau red staining at the top shows the GST proteins used.
Compared with control podocytes, podocytes transfected with PLCE1 siRNA exhibited a significant decrease in GTP-bound Rac1 and Cdc42 levels.
b, c Quantification of Rac1 (b) and Cdc42 (c) in PLCE1 knockdown cells compared to that in control cells. d Active GTP-bound RhoA precipitated from
podocytes transfected with PLCE1 siRNA using a GST-rhotekin (RBD domain) pulldown assay. Cells transfected with or without PLCE1 siRNA exhibited
no significant differences in GTP-bound RhoA. e Quantification of RhoA in PLCE1 knockdown cells compared with that in control cells. Error bars
indicate the standard deviations for more than three independent experiments. *P < 0.05; n.s. not significant.
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Fig. 5 NCK2 interacts with PLCE1 and affects the migration in podocytes. a, b Interaction of PLCE1 and NCKs. The plasmids containing FLAG-
tagged PLCE1 and Myc-tagged NCKs were transfected into podocytes, and cell lysates were immunoprecipitated using anti-FLAG agarose beads.
Notably, PLCE1 interacted with NCK2 (b) but not with NCK1 (a). The immunoblots are representative of more than three experiments. IP,
immunoprecipitation. c The effect of NCK2 knockout (KO) on podocyte migration. NCK2-depleted podocytes exhibited decreased migration (red and
orange lines) compared with that of the control podocytes (solid black line). Error bars are shown in only one direction for clarity and indicate
standard deviations for more than three independent experiments.
Fig. 4 Depletion of PLCE1 resulted in decreased podocyte migration and changed cell morphology. a Wound closure was reduced in
podocytes transfected with PLCE1 siRNAs (red and orange dots) compared to that in control podocytes (black dots). b Movement of cells into the
wound is shown at 1 and 17 h after scratching. PLCE1 knockdown podocytes showed delayed wound closure. c The effect of PLCE1 knockdown on
serum-induced podocyte migration. Podocytes transfected with PLCE1 siRNA (red and orange lines) exhibited decreased migration compared to that
of the control podocytes (solid black line). Error bars are shown in only one direction for clarity and indicate standard deviations for more than three
independent experiments. d, e The effect of PLCE1 knockout (KO) on podocyte morphology. PLCE1 KO resulted in the loss of terminal arborizations in
undifferentiated podocytes (d) and an increased number of stress fibers in differentiated PLCE1 KO podocytes relative to that in control podocytes (e).
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Indeed, PLCβ isoforms are essential for angiotensin II-
mediated activation of TRPC6 in podocytes28. Taken
together, the loss of phospholipase activity is not sufficient
to explain the pathogenesis of nephrotic syndrome
resulting from PLCE1 mutations.
Rho GTPases are key players in the regulation of actin
dynamics and cell migration21. Both increased and
decreased Rho GTPase signaling interfere with podocyte
mobility, thus causing proteinuria in humans and ani-
mal models29. RhoA directly activates the phospholipase
activity of PLCE112, but the active state of RhoA was not
affected in PLCE1 knockdown podocytes. However, it
was found that the levels of GTP-bound Rac1 and Cdc42
were decreased by the PLCE1 knockdown, which also
led to a reduction in the migratory phenotype of
podocytes. The podocyte-specific Cdc42 KO mouse
model exhibits severe proteinuria and early-onset FSGS,
whereas the podocyte-specific Rac1 KO mice are normal
but are more susceptible to chronic hypertensive
damage17. Therefore, decreased levels of active Cdc42
and Rac1 may have roles in PLCE1 mutation-induced
disease pathogenesis.
PLCE1 mutations are histologically associated with
DMS8,9, which is known to be characterized by a diffuse
increased mesangial matrix and immature glomeruli30. In
addition, podocytes are hypertrophic and have a cuboidal
(immature) appearance30. In this study, PLCE1 KO
podocytes exhibited reduced MAPK activation and cell
proliferation upon EGF stimulation. In addition, PLCE1
KO podocytes expressed low levels of podocyte markers
upon differentiation, indicating that they remain imma-
ture. These characteristics of PLCE1 KO podocytes could
explain the DMS observed upon analyzing the renal his-
tology in individuals with PLCE1 mutations.
NCK1 and NCK2 exhibited redundancy in podocytes, as
the simultaneous deletion of both genes, but not that of a
single gene, resulted in podocytopathy23. However, they
also have distinct functions. For example, NCK1, but not
NCK2, is ubiquitinated by c-Cbl, which competes with
synaptopodin for binding to NCK1 and protects NCK1
from proteasomal degradation. Then, NCK1 induces the
formation of stress fibers in cooperation with RhoA31. In
this study, it was found that PLCE1 interacts with NCK2
but not with NCK1. NCK2 KO resulted in the reduced
Fig. 6 PLCE1 regulates mitogen-activated protein kinases (MAPKs) in podocytes. a MAPK phosphorylation was induced by 20 ng/µl epidermal
growth factor (EGF) treatment for 45 or 120 min. EGF-induced phosphorylation of ERK and JNK was significantly reduced in PLCE1 knockout (KO)
podocytes. b, c The effects of PLCE1 or NCK2 KO on podocyte proliferation. PLCE1 KO podocytes exhibited lower proliferation (b, red and orange
lines), whereas NCK2 KO podocytes exhibited no significant differences in proliferation (c, red and orange lines) with respect to the control cells (black
line). Error bars are shown in one direction only for clarity and indicate standard deviations from more than three independent experiments. d
Expression analysis of podocyte markers. The expression of NEPH1, NPHS1, WT1, and SYNPO was measured by quantitative real-time PCR. The
expression of podocyte markers was significantly reduced in PLCE1 KO podocytes, whereas no difference in the levels of podocyte markers was
observed between NCK2 KO and control podocytes. Gene expression was normalized relative to that of actin. Data are presented as the mean ±
standard deviation (n= 3). *P < 0.05.
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migration of podocytes in a manner similar to that
observed upon PLCE1 knockdown. As the levels of active
Rac1 and Cdc42 were reduced upon PLCE1 knockdown,
it will be interesting to examine whether NCK2 regulates
Rac1 and Cdc42 along with PLCE1 in podocytes.
We revealed that PLCE1 plays multiple roles in podo-
cytes. Mutational analysis of PLCE1 revealed that muta-
tions are distributed uniformly throughout PLCE132.
Some frameshift mutations at the C-terminus of PLCE1
affect one or both of the RA domains, but the protein
retains intact phospholipase and RasGEF activities. It was
found that the RA domain is necessary for interacting
with Rac1 and RhoA, suggesting that these mutations may
be pathogenic as they dysregulate Rho GTPase signaling.
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